Until about the early 1990s, it was kind of laughable that you could develop a pill that would slow aging, said Richard Miller, a biogerontologist at the University of Michigan who heads one of three labs funded by the National Institutes of Health to test such promising substances on mice
Table 1, includes studies showing that Empagliflozin improved oxidative stress markers and NYHA functional class in T2DM patients with HFrEF (Nantsupawat et al., 2024)
More clinical evidence is needed before BPC-157 can be formally recognized as a treatment for specific medical conditions
It's a principle we live by at Real Peptides, where every batch of peptides is crafted with meticulous attention to amino-acid sequencing
Coli proteome and transcriptome with single-molecule sensitivity in single cells
However, EMS lesions inherently exhibit impaired mitophagy, leading to the persistent accumulation of dysfunctional mitochondria and increased ROS production